Home / Simvastatin / Canada
CA ATC C10AA01 · updated 2 Nov 2026
Simvastatin shortage in Canada
Is there a Simvastatin shortage in Canada?
Yes. As of 2 Nov 2026, 20 Simvastatin products are reported short in Canada, the first since 1 Apr 2017. The company estimate for the return is 13 Nov 2026 (latest 29 Jan 2027). Main reason: manufacturing problem.
Also short in Italy, Ireland, Austria, Belgium, Czechia, Sweden, Japan, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | MAR-SIMVASTATIN (100 Tablet) | MARCAN PHARMACEUTICALS INC | 1 Apr 2017 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-SIMVASTATIN (100 Tablet) | MARCAN PHARMACEUTICALS INC | 1 Apr 2017 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-SIMVASTATIN (100 Tablet) | MARCAN PHARMACEUTICALS INC | 5 Mar 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-SIMVASTATIN (100 Tablet) | MARCAN PHARMACEUTICALS INC | 1 May 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-SIMVASTATIN (500 Tablet) | MARCAN PHARMACEUTICALS INC | 1 May 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | MAR-SIMVASTATIN (500 Tablet) | MARCAN PHARMACEUTICALS INC | 2 May 2018 | not given | Distribution or logistics Delay in shipping of the drug |
| CA | RIVA-SIMVASTATIN (100) | LABORATOIRE RIVA INC | 31 Oct 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RIVA-SIMVASTATIN (30 & 100) | LABORATOIRE RIVA INC | 31 Oct 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RIVA-SIMVASTATIN (30 & 100) | LABORATOIRE RIVA INC | 31 Oct 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RIVA-SIMVASTATIN (30 & 100) | LABORATOIRE RIVA INC | 31 Oct 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RIVA-SIMVASTATIN (30) | LABORATOIRE RIVA INC | 31 Oct 2018 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-SIMVASTATIN (100) | JAMP PHARMA CORPORATION | 31 Oct 2025 | 25 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-SIMVASTATIN (100) | JAMP PHARMA CORPORATION | 12 Mar 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-SIMVASTATIN (30) | JAMP PHARMA CORPORATION | 21 Apr 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-SIMVASTATIN (PP 30) | TEVA CANADA LIMITED | 22 Apr 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | SIMVASTATIN (100) | SANIS HEALTH INC | 15 Jul 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-SIMVASTATIN (100's Bottle) | SUN PHARMA CANADA INC | 5 Aug 2026 | 29 Jan 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | SIMVASTATIN (100) | SANIS HEALTH INC | 24 Aug 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-SIMVASTATIN (30) | JAMP PHARMA CORPORATION | 15 Sep 2026 | 27 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-SIMVASTATIN (100 BTL) | APOTEX INC | 19 Oct 2026 | 13 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.